Heart Center and Laboratory Animal Center, Liaocheng People's Hospital of Shandong First Medical University, Liaocheng, Shandong, China.
Hospital Library, Liaocheng People's Hospital, Liaocheng, Shandong, China.
Front Public Health. 2023 Apr 6;11:1151038. doi: 10.3389/fpubh.2023.1151038. eCollection 2023.
In the early stage of COVID-19 epidemic, the Chinese mainland once effectively controlled the epidemic, but COVID-19 eventually spread faster and faster in the world. The purpose of this study is to clarify the differences in the epidemic data of COVID-19 in different areas and phases in Chinese mainland in 2020, and to analyze the possible factors affecting the occurrence and development of the epidemic.
We divided the Chinese mainland into areas I, I and III, and divided the epidemic process into phases I to IV: limited cases, accelerated increase, decelerated increase and containment phases. We also combined phases II and III as outbreak phase. The epidemic data included the duration of different phases, the numbers of confirmed cases, asymptomatic infections, and the proportion of imported cases from abroad.
In area I, II and III, only area I has a Phase I, and the Phase II and III of area I are longer. In Phase IV, there is a 17-day case clearing period in area I, while that in area II and III are 2 and 0 days, respectively. In phase III or the whole outbreak phase, the average daily increase of confirmed cases in area I was higher than that in areas II and III ( = 0.009 and = 0.001 in phase III; = 0.034 and = 0.002 in the whole outbreak phase), and the average daily in-hospital cases were most in area I and least in area III ( = 0.000, = 0.000, and = 0.000 in phase III; = 0.000, = 0.000, and = 0.009 in the whole outbreak phase). The average number of daily in-hospital COVID-19 cases in phase III was more than that in phase II in each area ( = 0.000, = 0.000, and = 0.001). In phase IV, from March 18, 2020 to January 1, 2021, the increase of confirmed cases in area III was higher than areas I and II (both = 0.000), and the imported cases from abroad in Chinese mainland accounted for more than 55-61%. From June 16 to July 2, 2020, the number of new asymptomatic infections in area III was higher than that in area II ( = ), while there was zero in area I. From July 3, 2020 to January 1, 2021, the increased COVID-19 cases in area III were 3534, while only 14 and 0, respectively, in areas I and II.
The worst epidemic areas in Chinese mainland before March 18, 2020 and after June 15, 2020 were area I and area III, respectively, and area III had become the main battlefield for Chinese mainland to fight against imported epidemic since March 18, 2020. In Wuhan, human COVID-19 infection might occur before December 8, 2019, while the outbreak might occur before January 16 or even 10, 2020. Insufficient understanding of COVID-19 hindered the implementation of early effective isolation measures, leading to COVID-19 outbreak in Wuhan, and strict isolation measures were effective in controlling the epidemic. The import of foreign COVID-19 cases has made it difficult to control the epidemic of area III. When humans are once again faced with potentially infectious new diseases, it is appropriate to first and foremost take strict quarantine measures as soon as possible, and mutual cooperation between regions should be explored to combat the epidemic.
在 COVID-19 疫情早期,中国大陆曾有效控制疫情,但 COVID-19 最终在世界范围内传播得越来越快。本研究旨在阐明 2020 年中国大陆不同地区和不同阶段 COVID-19 疫情数据的差异,并分析可能影响疫情发生和发展的因素。
我们将中国大陆分为地区 I、II 和 III,并将疫情过程分为 I 至 IV 期:有限病例期、加速增长期、减速增长期和控制期。我们还将 II 期和 III 期合并为爆发期。疫情数据包括不同阶段的持续时间、确诊病例、无症状感染病例以及来自国外的输入病例的比例。
在地区 I、II 和 III 中,只有地区 I 有 I 期,地区 I 的 II 期和 III 期较长。在 IV 期,地区 I 的病例清零期为 17 天,而地区 II 和 III 的病例清零期分别为 2 天和 0 天。在 III 期或整个爆发期,地区 I 的确诊病例平均日增长率高于地区 II 和 III(III 期=0.009,=0.001;整个爆发期=0.034,=0.002),住院病例平均日增长率最高的是地区 I,最低的是地区 III(III 期=0.000,=0.000,=0.000;整个爆发期=0.000,=0.000,=0.009)。III 期的住院 COVID-19 病例日平均数高于 II 期(=0.000,=0.000,=0.001)。在 IV 期,从 2020 年 3 月 18 日至 2021 年 1 月 1 日,地区 III 的确诊病例增长率高于地区 I 和 II(均=0.000),中国大陆的输入病例占比超过 55-61%。从 2020 年 6 月 16 日至 7 月 2 日,地区 III 的新增无症状感染病例数高于地区 II(=),而地区 I 则为零。从 2020 年 7 月 3 日至 2021 年 1 月 1 日,地区 III 的 COVID-19 新增病例数为 3534 例,而地区 I 和 II 分别只有 14 例和 0 例。
中国大陆在 2020 年 3 月 18 日之前和 6 月 15 日之后疫情最严重的地区分别是地区 I 和地区 III,自 2020 年 3 月 18 日以来,地区 III 已成为中国大陆抗击输入性疫情的主要战场。在武汉,人类可能在 2019 年 12 月 8 日之前感染了 COVID-19,而疫情可能在 1 月 16 日或更早的 10 日发生。对 COVID-19 的认识不足阻碍了早期有效隔离措施的实施,导致了武汉的疫情爆发,严格的隔离措施在控制疫情方面是有效的。国外 COVID-19 病例的输入使得地区 III 的疫情难以控制。当人类再次面临潜在传染性的新疾病时,尽快采取严格的隔离措施是适当的,还应探索地区间的相互合作,以对抗疫情。